- GreenRush Analytical Labs (GAL) is a wholly owned Subsidiary of Next Gen
- The Mission of GreenRush Analytical Labs; is to provide analytical testing for the Legal Cannabis Industry in North America by delivering customized solutions and accurate analytical results to our clients.
- The Vision of GreenRush Analytical Labs; is to become a leading Laboratory company focused on servicing the legalized cannabis industry in North America.
- Proposed new Canadian Medical Marijuana and Industrial Hemp laws and regulations are anticipated to set additional standards for licensed producers that require more detailed Quality control and Quality assurances from Licensed Producers.
- Anticipated new legislation in the United States for medical/recreational Marijuana and Industrial Hemp can derive unprecedented growth in these new Multi-Billion Dollars industries
VANCOUVER, May 6, 2014 /CNW/ - Next Gen Metals Inc. ("Next Gen", the "Company") (CSE: N, OTC Pink: NXTTF, FSE: M5BN) is pleased to announce that it has established its second %100 owned subsidiary, GreenRush Analytical Laboratories Inc. (GAL). The Mission of GreenRush Analytical Laboratories Inc. is to provide analytical testing for the Legal Cannabis Industry in North America by delivering customized solutions and accurate analytical results to our clients.
Next Gen's competitive advantages include:
- Management's financial contacts to raise venture capital
- Management's ability to efficiently manage both public and private companies on an International scale
- Management's ability to negotiate equitable deals for our shareholders and partners
- Management's ability to Complete its objectives on time and on budget
GAL is organizing a team of scientists and laboratory technicians to staff our first Laboratory. Simultaneously GAL's management continues to meet with targeted under-funded Analytical Laboratory opportunities for possible mergers and acquisitions.
With over 300 years of experience and managing public and private companies, negotiating complex deals and raising venture capital our Management team has completed over 300 option/joint venture agreements with major, mid-tier and junior companies and have raised over $250,000,000 in equity to advance projects across the world.
Harry Barr, President and CEO stated, "New laws and legislations in Canada and in the United States allow production of Legal/Medical Marijuana. An increasing number of U.S states have allowed Licensed Producers, to produce Medical Marijuana. Additionally, to date, two States have legalized Recreational Marijuana.
In Canada; new federal laws (April 1st 2014) allowed for Licensed Producers to establish new legal Marijuana grow up operations to produce Marijuana. To that end ,and as of today, there are currently thirteen Licensed Producers in Canada and over 650 applications in progress.
This unpredicted growth in this new multi-billion dollars industry has allowed the directors and management of Next Gen to provide an increasing number of financial solutions for the Medical Marijuana and Industrial Hemp industries."
Management is currently in the process of assessing and selecting initial locations and jurisdictions to establish the laboratories. Management's objective is to initiate analytical laboratories in areas with the greatest concentration of Licensed Producers in both the legal Medical Marijuana and Industrial Hemp industries.
Under the new MMPR program, companies that wish to grow and sell medical marijuana must follow a strict set of rules, including quality control and data keeping protocols.
For example, each batch of cannabis must be tested for pesticides, mold and contaminants, in addition to chemical composition, before being sold.
New standards for quality control and quality assurance in the USA and in Canada are deriving increased demand for these analytical tests and procedures. Three main purposes for Medical Cannabis and Industrial
Hemp testing are:
1. Health Canada requirements
2. Patient and consumer safety
3. Limiting liability for Licensed Producers
Health Canada estimates that the market could be worth $1.3 billion by 2024. Analysts and industry experts peg estimates to be closer to $2.6 billion by 2016.
The medical community, health givers and patients demanding product testing to understand the safety and the strength of a particular product, and find the best medicine to alleviate their particular ailments.
In light of Next Gen's vision and having completed our first two investments, Management's objective is to invest in a basket of company's within this growing industry. The company's business model continues to generate new business plans and project submittals 24/7.
About GreenRush Financial Conferences
GreenRush Conferences shares a similar vision as its sole shareholder Next Gen (PubCo, CSE: N, OTC Pink: NXTTF, FSE: M5BN): a vision to provide a forum for venture capital investment, education, business to business opportunities as well as act as a facilitator for this emerging industry.
The conference will feature insightful speakers, government, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Conferences will be tailored to institutional, high net worth and retail investors with a focus on education and investment in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.
Investors and other interested parties are invited to attend and learn about investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine business sector
The first conference will held in Vancouver, British Columbia on Wednesday May 7th, 2014 at the Vancouver Convention and Exhibition Centre East, Ballrooms A/B/C in the Pan Pacific Hotel. The company is planning a second conference to be held in Toronto, Conference Centre, Ontario on June 26th, 2014 at Toronto's Conference Centre. Further conferences are also slated for other cities in Canada and the United States and Europe.
About Next Gen
(CSE: N, OTC Pink: NXTTF, FSE: M5BN)
Next Gen is a diversified Canadian public company which focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi-billion dollar industry.
Next Gen's vision is to be the leading provider of venture capital, management expertise, education and a facilitator for this explosive new industry.
Our business model generates dozens of new business plans and industry related proposals on an ongoing basis. Management continues to receive and review the proposals from various segments of the industry including: alternative medicine, health, food, agri-business, legal grow-ops, technology, client generation, education, public awareness, specialty clinics and ancillary business opportunities. For further information, visit our website at www.nextgenmetalsinc.com.
On March 20, 2014, Next Gen Metals announce that it has established its first wholly owned subsidiary, a Conference Division, that intends to host Canada's first conferences focused on business to business opportunities, investment and education in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.
On May 6th, 2014 Next Gen announced the establishment of its second wholly owned subsidiary GreenRush Analytical Laboratories Inc. GreenRush Analytical Laboratories Inc. will provide analytical testing to the cannabis industry by delivering customized solutions and accurate analytical results and ensure the health and safety of consumers. GreenRush Analytical Laboratories Inc. would be dedicated to helping physicians and health care providers improve patient health.
In light of Next Gen's vision, Management's intention is to invest in a basket of companies within this growing industry. The company's business model continues to generate new business plans and project submittals 24/7.
On behalf of the Board of Directors
President & CEO
FORWARD LOOKING INFORMATION
This News Release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements.
Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com. This News Release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this News Release
 Health Canada- http://www.hc-sc.gc.ca/dhp-mps/marihuana/info/list-eng.php
 (Marihuana for Medical Purposes Regulations, Division 4 Good Production Practices, sections 52-55)
SOURCE: Next Gen Metals Inc.
For further information: For more information on GreenRush Conferences please visit our website at www.greenrushfinancialconferences.com, email us at email@example.com or contact us by phone at (604) 685-1870; For further information on GreenRush Analytical Laboratories Inc. please visit us at www.nextgenmetalsinc.com